| # | Drug | Count |
|---|---|---|
| 0 | RIOCIGUAT | 59 |
| 1 | MACITENTAN | 36 |
| 2 | WARFARIN | 21 |
| 3 | TREPROSTINIL | 15 |
| 4 | AMBRISENTAN | 14 |
| 5 | RIVAROXABAN | 14 |
| 6 | SELEXIPAG | 11 |
| 7 | APIXABAN | 7 |
| 8 | BOSENTAN | 7 |
| 9 | 0XYGEN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAFTIFINE HYDROCHLORIDE | 1 | 0.0042 |
| 1 | RIOCIGUAT | 59 | 0.0036 |
| 2 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0016 |
| 3 | MACITENTAN | 36 | 0.0010 |
| 4 | SELEXIPAG | 11 | 0.0009 |
| 5 | EPOPROSTENOL SODIUM | 5 | 0.0008 |
| 6 | FOSTAMATINIB | 1 | 0.0008 |
| 7 | CICLOPIROX | 1 | 0.0007 |
| 8 | GLUCAGON | 1 | 0.0005 |
| 9 | ANTIBIOTIC | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Soluble Guanylate Cyclase Stimulator [EPC] | 59 |
| 1 | Endothelin Receptor Antagonist [EPC] | 49 |
| 2 | Factor Xa Inhibitor [EPC] | 21 |
| 3 | Prostacycline Vasodilator [EPC] | 18 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 11 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 6 |
| 6 | Aldosterone Antagonist [EPC] | 5 |
| 7 | Loop Diuretic [EPC] | 4 |
| 8 | Progestin [EPC] | 4 |
| 9 | Estrogen [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Soluble Guanylate Cyclase Stimulator [EPC] | 59 | 0.0036 |
| 1 | Prostacyclin Receptor Agonist [EPC] | 11 | 0.0009 |
| 2 | Antihypoglycemic Agent [EPC] | 1 | 0.0005 |
| 3 | Endothelin Receptor Antagonist [EPC] | 49 | 0.0004 |
| 4 | Prostacycline Vasodilator [EPC] | 18 | 0.0002 |
| 5 | Non-narcotic Antitussive [EPC] | 2 | 0.0002 |
| 6 | Prostacycline [EPC] | 1 | 0.0001 |
| 7 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 8 | Factor Xa Inhibitor [EPC] | 21 | 0.0001 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 6 | 0.0001 |